CTOs on the Move

RSi Communications Group

www.rsicommunications.com

 
RSi Communications Group is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MedStartr

Millions of Patients around the world are standing up and taking an active role in their health, including supporting the care innovations that matter most to them.   MedStartr enables patients, doctors, institutions, partners, and investors to find and fund the best ideas in healthcare and bring them to life. Join us today!

Orlando Senior Health Network

Orlando Senior Health Network is a network of companies that provides a broad range of residential living options, home care and rehabilitation services, plus pharmaceutical and medical equipment offerings, designed to improve the quality of life for s...

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

SaluGenecists Inc

SaluGenecists Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genesis HealthCare System

Genesis HealthCare System was created in 1997 as an affiliation between Bethesda Care System and Good Samaritan Medical Center — two health care organizations that had served the community for more than 100 years each. We are a not-for-profit organization that operates two hospital sites — Genesis-Bethesda and Genesis-Good Samaritan — in Zanesville, Ohio, and several affiliated health care organizations. By combining the resources of the two organizations, we have been able to provide several new services for the community, including open-heart surgery, a Level II neonatal intermediate care unit and enhanced cancer services. Our primary service area is a six-county region of southeastern Ohio, including Muskingum, Morgan, Perry, Coshocton, Noble and Guernsey counties.